Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial

被引:3
作者
Laursen, Jens Christian [1 ]
Curovic, Viktor Rotbain [1 ]
Kroonen, Marjolein Y. A. M. [2 ]
Jongs, Niels [2 ]
Zobel, Emilie H. [1 ]
Hansen, Tine W. [1 ]
Frimodt-Moller, Marie [1 ]
Laverman, Gozewijn D. [3 ]
Kooy, Adriaan [4 ,5 ]
Persson, Frederik [1 ]
Heerspink, Hiddo J. L. [2 ]
Hansen, Christian Stevns [1 ]
Rossing, Peter [1 ,6 ]
机构
[1] Steno Diabet Ctr Copenhagen, Borgmester Ib Juuls Vej 83, Herlev, Denmark
[2] Univ Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[3] Ziekenhuis Grp Twente, Almelo, Netherlands
[4] Bethesda Diabet Res Ctr, Hoogeveen, Netherlands
[5] Univ Groningen, Dept Internal Med, Groningen, Netherlands
[6] Univ Copenhagen, Copenhagen, Denmark
关键词
clinical trial; diabetes complications; diabetic neuropathy; empagliflozin; linagliptin; SGLT2; inhibitor; ALBUMINURIA;
D O I
10.1111/dom.15180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3064 / 3067
页数:4
相关论文
共 12 条
[1]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[2]   Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial [J].
Curovic, Viktor Rotbain ;
Jongs, Niels ;
Kroonen, Marjolein Y. A. M. ;
Zobel, Emilie H. ;
Hansen, Tine W. ;
Sen, Taha ;
Laverman, Gozewijn D. ;
Kooy, Adriaan ;
Persson, Frederik ;
Rossing, Peter ;
Heerspink, Hiddo J. L. .
DIABETES CARE, 2023, 46 (03) :593-601
[3]   Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus [J].
Didangelos, Triantafyllos ;
Tziomalos, Konstantinos ;
Margaritidis, Charalambos ;
Kontoninas, Zisis ;
Stergiou, Ioannis ;
Tsotoulidis, Stefanos ;
Karlafti, Eleni ;
Mourouglakis, Alexandros ;
Hatzitolios, Apostolos I. .
JOURNAL OF DIABETES RESEARCH, 2017, 2017
[4]   Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction [J].
Groop, Per-Henrik ;
Cooper, Mark E. ;
Perkovic, Vlado ;
Emser, Angela ;
Woerle, Hans-Juergen ;
von Eynatten, Maximilian .
DIABETES CARE, 2013, 36 (11) :3460-3468
[5]   Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy [J].
Howorka, K ;
Pumprla, J ;
Haber, P ;
KollerStrametz, J ;
Mondrzyk, J ;
Schabmann, A .
CARDIOVASCULAR RESEARCH, 1997, 34 (01) :206-214
[6]   Hyperoxia improves autonomic function in individuals with long-duration type 1 diabetes and macroalbuminuria [J].
Laursen, J. C. ;
Hansen, C. S. ;
Bordino, M. ;
Vistisen, D. ;
Zobel, E. H. ;
Winther, S. A. ;
Groop, P-H ;
Frimodt-Moller, M. ;
Bernardi, L. ;
Rossing, P. .
DIABETIC MEDICINE, 2020, 37 (09) :1561-1568
[7]   Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study [J].
Martin, Catherine L. ;
Albers, James W. ;
Pop-Busui, Rodica .
DIABETES CARE, 2014, 37 (01) :31-38
[8]   Direct renin inhibition improves parasympathetic function in diabetes [J].
Maser, R. E. ;
Lenhard, M. J. ;
Kolm, P. ;
Edwards, D. G. .
DIABETES OBESITY & METABOLISM, 2013, 15 (01) :28-34
[9]   The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients [J].
Petrykiv, Sergei I. ;
Laverman, Gozewijn D. ;
de Zeeuw, Dick ;
Heerspink, Hiddo J. L. .
DIABETES OBESITY & METABOLISM, 2017, 19 (10) :1363-1370
[10]   Diabetic Neuropathy: A Position Statement by the American Diabetes Association [J].
Pop-Busui, Rodica ;
Boulton, Andrew J. M. ;
Feldman, Eva L. ;
Bril, Vera ;
Freeman, Roy ;
Malik, Rayaz A. ;
Sosenko, Jay M. ;
Ziegler, Dan .
DIABETES CARE, 2017, 40 (01) :136-154